New York, Aug. 23, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) and Parent Project Muscular Dystrophy (PPMD) today announced the publication of jointly developed consensus ...
Macrophages, a type of white blood cell involved in inflammation, readily take up a newly approved medication for Duchenne muscular dystrophy (DMD) and promote its sustained delivery to regenerating ...
BOSTON and OXFORD, United Kingdom, March 15, 2021 /PRNewswire/ -- PepGen, an emerging biotechnology company focused on developing transformative therapies for individuals living with neuromuscular and ...
RANDOLPH, Mass. and CAMBRIDGE, Mass., June 20, 2023 (GLOBE NEWSWIRE) -- Today on World FSHD Day, the FSHD Society and Fulcrum Therapeutics (FULC) announce the launch of Project Mercury, a first-of-its ...
NORCO, Calif. & COLUMBUS, Ohio--(BUSINESS WIRE)--Destroy Duchenne, a nonprofit organization founded by DMD patient, Elijah Stacy that aims to Complete the Cure TM for Duchenne Muscular Dystrophy (DMD) ...
Oct. 16 (UPI) --Researchers at Children's National Health System found chronic inflammation is vital for sustained delivery of drug treatment for Duchenne muscular dystrophy. Since the drug eteplirson ...
New preclinical data demonstrates the ability of SonoThera’s novel, nonviral UMD technology to deliver genetic medicines, allowing for full-length dystrophin protein expression in skeletal, cardiac ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback